News from the San Antonio Breast Cancer Symposium
When: Wednesday, January 9, 2013
Noon - 1:00 p.m. EST
The San Antonio Breast Cancer Symposium, one of the largest meetings for breast cancer research, provides updates that can empower you to make the best possible decisions for your care. During our January webinar, Sara M. Tolaney, MD, MPH, discussed findings presented at the symposium, including:
- Updates on chemotherapy, hormonal therapies and targeted therapies for early-stage and metastatic disease
- New options for managing symptoms and side effects
About Our Speaker
Dr. Tolaney is a medical oncologist at Dana-Farber Cancer Institute in Boston, Mass., where she focuses on developing new treatments for breast cancer. She is also a medical instructor at Harvard Medical School.
Dr. Tolaney received her undergraduate degree from Princeton University in 1998 and her medical degree from the University of California, San Francisco in 2002. She completed her residency in internal medicine at Johns Hopkins University and a fellowship in hematology-oncology at the Dana-Farber Cancer Institute.
This webinar is made possible in part due to the generous support of